IL6 and COVID-19: The most significant association of genetically instrumented IL-6 was observed with COVID-19 hospitalization, i.e., HGI_ALL_B2 (OR (CI 95%) = 0.48 (0.30–0.76), p = 0.002) (Figure 4, Table S3).